Avelumab added to FOLFIRI plus Cetuximab followed by Avelumab maintenance in patients with previously untreated RAS wild-type colorectal cancer - The phase II FIRE-6-Avelumab study

ABSTRACT: Primary objectives: The primary objective of the study is to assess the efficacy of FOLFIRI plus cetuximab incombination with avelumab followed by avelumab maintenance therapy in patients withpreviously untreated RAS/BRAF wild-type mCRC. Primary endpoints: • Progression-free survival (PFS) according to RECIST v1.1

DISEASE(S): Metastatic Colorectal Cancer,Avelumab Added To Folfiri Plus Cetuximab Followed By Avelumab Maintenance In Patients With Previously Untreated Ras/braf Wild-type Metastatic Colorectal Cancer - The Phase Ii Fire-6-avelumab Study

PROVIDER: 2538194 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR